[HTML] sciencedirect.comFull View

[HTML][HTML] Study of bioaccumulation of dalteparin at a prophylactic dose in patients with various degrees of impaired renal function

P Schmid, D Brodmann, AG Fischer… - Journal of Thrombosis and …, 2009 - Elsevier
Background: Low-molecular-weight heparins (LMWH) have been shown to be effective and
safe for prophylaxis of thromboembolic diseases. However, issues regarding safety and …
被引用次数：50 相关文章

Study of bioaccumulation of dalteparin at a prophylactic dose in patients with various degrees of impaired renal function

P SCHMID, D BRODMANN… - … of Thrombosis and …, 2009 - Wiley Online Library
Background: Low‐molecular‐weight heparins (LMWH) have been shown to be effective and
safe for prophylaxis of thromboembolic diseases. However, issues regarding safety and …

Study of bioaccumulation of dalteparin at a prophylactic dose in patients with various degrees of impaired renal function.

P Schmid, D Brodmann, AG Fischer… - Journal of Thrombosis …, 2009 - europepmc.org
Background Low-molecular-weight heparins (LMWH) have been shown to be effective and
safe for prophylaxis of thromboembolic diseases. However, issues regarding safety and …
[HTML] jthjournal.org

[HTML][HTML] Study of bioaccumulation of dalteparin at a prophylactic dose in patients with various degrees of impaired renal function

P SCHMID, D BRODMANN, AG FISCHER… - Journal of Thrombosis …, 2009 - jthjournal.org
Background: Low-molecular-weight heparins (LMWH) have been shown to be effective and
safe for prophylaxis of thromboembolic diseases. However, issues regarding safety and …

Study of bioaccumulation of dalteparin at a prophylactic dose in patients with various degrees of impaired renal function

P Schmid, D Brodmann, AG Fischer… - … of thrombosis and …, 2009 - pubmed.ncbi.nlm.nih.gov
Background Low-molecular-weight heparins (LMWH) have been shown to be effective and
safe for prophylaxis of thromboembolic diseases. However, issues regarding safety and …